Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues
Niagen Bioscience, Inc. (NAGE) had Gross Margin of 64.28% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$129.42M |
|
$17.38M |
|
$46.23M |
|
$83.19M |
|
$113.14M |
|
$16.28M |
|
$1.91M |
|
$18.19M |
|
$18.19M |
|
$17.38M |
|
$17.38M |
|
$17.38M |
|
$17.38M |
|
$16.28M |
|
$17.06M |
|
79.18M |
|
85.44M |
|
$0.22 |
|
$0.20 |
|
| Balance Sheet Financials | |
$96.81M |
|
$1.32M |
|
$9.60M |
|
$106.41M |
|
$19.92M |
|
-- |
|
$9.95M |
|
$29.87M |
|
$76.53M |
|
$70.87M |
|
$76.53M |
|
79.71M |
|
| Cash Flow Statement Financials | |
$13.50M |
|
$-0.29M |
|
$6.92M |
|
$44.66M |
|
$64.79M |
|
$20.13M |
|
$6.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.86 |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Gross Margin |
64.28% |
12.58% |
|
12.58% |
|
13.18% |
|
14.06% |
|
13.43% |
|
$13.21M |
|
-- |
|
-- |
|
-- |
|
1.22 |
|
2.26 |
|
13.29 |
|
27.47 |
|
22.71% |
|
24.53% |
|
16.34% |
|
22.71% |
|
$0.96 |
|
$0.15 |
|
$0.16 |
|